Orchestra BioMed Holdings, Inc.
US ˙ NasdaqGM ˙ US68572M1062

SecurityOBIO / Orchestra BioMed Holdings, Inc.
InstitutionIFP Advisors, Inc
Latest Disclosed Ownership98,887 shares
Latest Disclosed Value $ 420,270
IFP Advisors, Inc reports 14.06% increase in ownership of OBIO / Orchestra BioMed Holdings, Inc.

On April 13, 2026 - IFP Advisors, Inc filed a 13F-HR form disclosing ownership of 98,887 shares of Orchestra BioMed Holdings, Inc. (US:OBIO) valued at $420,270 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 86,698 shares of Orchestra BioMed Holdings, Inc.. This represents a change in shares of 14.06% during the quarter. The current value of the position is $394,559 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F ORCHESTRA BIOMED HLDGS cs 68572M106 98,887 12,189 14.06 420 16.99 0.0087
2026-02-06 2025-12-31 13F ORCHESTRA BIOMED HLDGS cs 68572M106 86,698 0 0.00 360 66.98 0.0081
2026-02-06 2025-09-30 13F/A-1 ORCHESTRA BIOMED HLDGS cs 68572M106 86,698 1,340 1.57 215 -5.70 0.0056
2025-12-02 2025-09-30 13F ORCHESTRA BIOMED HLDGS cs 68572M106 86,698 1,340 215 0.0055
2025-07-24 2025-06-30 13F ORCHESTR A BIOMED HLDGS cs 68572M106 85,358 -76,563 -47.28 229 -67.10 0.0065
2025-05-05 2025-03-31 13F ORCHESTRA BIOMED HLDGS cs 68572M106 161,921 83,481 106.43 693 121.41 0.0214
2025-02-04 2024-12-31 13F ORCHESTRA BIOMED HLDGS cs 68572M106 78,440 -749 -0.95 314 -23.10 0.0103
2025-02-04 2024-09-30 13F ORCHESTRA BIOMED HLDGS cs 68572M106 79,189 4,081 5.43 407 -33.50 0.0147
2024-07-30 2024-06-30 13F ORCHESTRA BIOMED HLDGS cs 68572M106 75,108 15,986 27.04 612 96.78 0.0243
2024-07-30 2024-03-31 13F ORCHESTRA BIOMED HLDGS cs 68572M106 59,122 54,992 1,331.53 312 740.54 0.0137
2024-01-09 2023-12-31 13F ORCHESTRA BIOMED HLDGS cs 68572M106 4,130 0 0.00 38 2.78 0.0018
2023-10-12 2023-09-30 13F ORCHESTRA BIOMED HLDGS cs 68572M106 4,130 0 0.00 36 28.57 0.0016
2023-08-14 2023-06-30 13F/A-1 ORCHESTRA BIOMED HLDGS cs 68572M106 4,130 1,150 38.59 29 -17.65 0.0012
2023-08-04 2023-06-30 13F ORCHESTRA BIOMED HLDGS cs 68572M106 4,130 1,150 47 0.0022
2023-04-18 2023-03-31 13F ORCHESTRA BIOMED HLDGS cs 68572M106 2,980 2,980 34 0.0015
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.